Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer

Figure 3

Irinotecan response is increased when DEK is silenced. Diagram shows percentage of apoptotic cells stained with Annexin-V after treatments. DLD1 and SW620 cell lines were DEK knocked-down and treated with SN38 or 5FU separately and compared with control cells (control siRNA and untreated). Combination of siDEK and SN38 increased apoptosis (P < 0.05) compared to control or DEK silenced in both cell lines. In addition, combination increased apoptosis (P < 0.05) compared to single SN38 treatment in DLD1 cell line. No significant differences were observed after 5FU treatment. Results are expressed as the average of downregulation with 2 different siRNA sequences (siDEKsec57 and 58) in triplicate.

Back to article page
\